Literature DB >> 3900645

Characterization of pathogenic constituents of Cryptococcus neoformans strains.

K Kagaya, T Yamada, Y Miyakawa, Y Fukazawa, S Saito.   

Abstract

We examined seven strains, comprising five serotypes, of Cryptococcus neoformans to determine what constituents of the organisms are responsible for pathogenicity and virulence in BALB/c mice. C. neoformans strains were divided into three virulence classes by survival rates after intravenous inoculation of 1 X 10(5) or 1 X 10(7) viable cells, and virulence was found not to be correlated with serotype or capsular size. C. neoformans cells resisted phagocytosis in different degrees in the presence of normal serum. Sensitivity of the C. neoformans strains to singlet oxygen ranged from resistance to susceptibility. Histological examination revealed that a weakly encapsulated virulent strain induced inflammatory responses with granuloma formation in the liver, lung, and kidney in addition to formation of cystic foci in the brain. In contrast, although the heavily encapsulated virulent strain produced granulomatous lesions in the liver, this strain preferably produced mucinous cystic foci in the lung, kidney, and brain. Correlation between virulence, and biological, histopathological and physiological evidence suggests that C. neoformans strains are endowed with the implicated multiple pathogenic constituents in various degrees and proportions. The following are suggested as the most important pathogenic constituents: a polysaccharide capsule responsible for resistance to phagocytosis and formation of cystic foci; a cell surface structure for responsible for resistance to intra- or extracellular killing and induction of the granulomatous lesion; a growth rate suitable for interacting with phagocytic elimination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900645     DOI: 10.1111/j.1348-0421.1985.tb00854.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  9 in total

1.  Expression of capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Rui Kano; Shinichi Watanabe; Atsuhiko Hasegawa
Journal:  Mycopathologia       Date:  2005-08       Impact factor: 2.574

2.  Isolation and characterization of a species-specific DNA fragment for detection of Candida albicans by polymerase chain reaction.

Authors:  Y Miyakawa; T Mabuchi; K Kagaya; Y Fukazawa
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 3.  Microreview: capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Atsuhiko Hasegawa; Toshi Watanabe
Journal:  Mycopathologia       Date:  2007-01       Impact factor: 2.574

4.  Electron microscopic cytochemical analysis of hepatic granuloma induced by Cryptococcus neoformans.

Authors:  T Baba
Journal:  Mycopathologia       Date:  1988-10       Impact factor: 2.574

5.  Intravascular granuloma induced by intravenous inoculation of Cryptococcus neoformans.

Authors:  H Yamaoka; N Sakaguchi; K Sano; M Ito
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

6.  Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.

Authors:  J M Small; T G Mitchell; R W Wheat
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

8.  Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

9.  The granuloma in cryptococcal disease.

Authors:  Laura C Ristow; J Muse Davis
Journal:  PLoS Pathog       Date:  2021-03-18       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.